Story thread · 2 reports / 2 sources
AbbVie’s Humira Cash Cow Is Shrinking—Can Its Dividend Keep Growing?
247wallst.com · 10d · first report
How the coverage leans
Across 2 sources · syndicated copies counted once
AbbVie's flagship drug is bleeding revenue quarter after quarter, yet the company just handed shareholders another raise. Find out whether the cash machine holding this payout together can survive the patent reckoning already underway.
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.